Clinical Trials Browser

Phase 1/2 × amrubicin × Breast × Clear all

NCT01033032 2022-05-03

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Phase 1/2 Completed

78 enrolled 15 charts

Breast Neoplasms